The shrine of knowledge.

Aripiprazole Pharmacokinetics

Aripiprazole Pharmacokinetics is described in multiple online sources, as addition to our editors' articles, see section below for printable documents, Aripiprazole Pharmacokinetics books and related discussion.

Suggested News Resources

Alkermes plc (ALKS) Tops Q4 EPS by 3c; Announces Positive Top-Line Data from
The company also announced positive topline data from a randomized, open-label, pharmacokinetic (PK) study evaluating a two-month dosing interval of ARISTADA® (aripiprazole lauroxil) extended-release injectable suspension for the treatment of ...
FDA Approves Deltoid Injection Site for Abilify Maintena® (aripiprazole) for
The pharmacokinetics, safety and tolerability of Abilify Maintena administered in the deltoid muscle compared to the gluteal muscle was evaluated in two, open-label studies in stable patients aged 18-64 years with a current diagnosis of schizophrenia.
Alkermes plc (ALKS) Hits Milestones in CNS Product and Pipeline Portfolio
Additionally, the company announced a newly issued patent expiring in 2033 that extends patent coverage for ARISTADA™ (aripiprazole lauroxil) extended-release injectable suspension for the treatment of schizophrenia.
Rezolsta (darunavir, cobicistat)
Cobicistat is a type of medicine known as a pharmacokinetic enhancer. AIDS (acquired immune deficiency syndrome) is caused by infection with HIV (human immunodeficiency virus). This virus invades cells of the immune system, particularly the white blood ...
Portage's Biohaven announces Phase 1 pharmacokinetic study meets study
He has been involved in multiple research and development programs including marketed drugs such as ABILIFY® (aripiprazole; partial dopamine agonist), OPDIVO® (nivolumab; anti-PD1), YERVOY® (Ipilimumab; anti-CTLA-4), DAKLINZA® (daclatasvir; ...

Great care has been taken to prepare the information on this page. Elements of the content come from factual and lexical knowledge databases, library and third-party sources. We appreciate your suggestions and comments on further improvements of the site.

Discussion Forum
Place for your opinion